Clinical Trial Update: Methylphenidate in Treating Patients With Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating methylphenidate for fatigue in patients with melanoma and unspecified adult solid tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Melanoma
• Unspecified Adult Solid Tumor

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific | Phase 3 | Status: COMPLETED